Qlt Inc (QLTI): Broadfin’s Kevin Kotler to Become Director of Novelion

Page 7 of 8 – SEC Filing
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
September 12, 2016
(Date)
BROADFIN CAPITAL, LLC
By:  /s/ Kevin Kotler
        Kevin Kotler, Managing Member
KEVIN KOTLER
    /s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:  /s/ Kevin Kotler
        Kevin Kotler, Director
Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)